GSK3B and Alzheimer disease: Moreover, we did not find a significant alteration in phospho-Ser9 of GSK-3β in AD P-tau injected hippocampus, supporting that GSK-3β probably does not contribute to AD P-tau-induced tau hyperphosphorylation.